Dr. Mark D. Romer, MD
Hematology & Oncology (Hematology & Oncology Physician)
- Medicare participating
At a glance
- Medical school
- University of Cincinnati College of Medicine (1986)
- Years since graduation
- 40
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 629
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1986Medical school: University of Cincinnati College of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Hematology & Oncology Physician primary
OH license 35055583 -
Medical Oncology Physician
OH license 35.055583
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Miami Valley Hospital Dayton, OH
- Kettering Health Dayton Dayton, OH
- Kettering Health Main Campus Kettering, OH
Medical groups
- Dayton Physicians LLC (41 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 629
- Services billed
- 142,864
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Injection, pembrolizumab, 1 mg | 12,200 | 19 |
| Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 10,305 | 14 |
| Injection, fosaprepitant, 1 mg | 9,150 | 32 |
| Injection, ferric carboxymaltose, 1 mg | 9,000 | 11 |
| Injection, iron sucrose, 1 mg | 6,000 | 20 |
| Injection, denosumab, 1 mg | 5,040 | 35 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 3,500 | 28 |
| Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 2,390 | 12 |
| Injection, dexamethasone sodium phosphate, 1 mg | 1,318 | 48 |
| Injection, palonosetron hcl, 25 mcg | 901 | 40 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Anastrozole Other prescribers in Dayton, OH | 147 |
| Oxycodone Hcl Other prescribers in Dayton, OH | 136 |
| Imbruvica (ibrutinib) | 112 |
| Ibrance (palbociclib) | 96 |
| Letrozole Other prescribers in Dayton, OH | 71 |
| Hydroxyurea Other prescribers in Dayton, OH | 70 |
| Lenalidomide | 67 |
| Eliquis (apixaban) Other prescribers in Dayton, OH | 65 |
| Ondansetron Hcl Other prescribers in Dayton, OH | 59 |
| Dexamethasone Other prescribers in Dayton, OH | 50 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 45 companies reported 137 payments worth $2,754 in total to this clinician.
| Novartis Pharmaceuticals Corporation | $292 |
|---|---|
| AstraZeneca Pharmaceuticals LP | $212 |
| Merck Sharp & Dohme LLC | $182 |
| Pfizer Inc. | $143 |
| Lilly USA, LLC | $117 |
| AbbVie Inc. | $112 |
| Janssen Biotech, Inc. | $101 |
| Genentech USA, Inc. | $90.92 |
| Food and Beverage | $2,731 |
|---|---|
| Education | $23.10 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP Apr 24, 2025 | Education in-kind Company’s descriptionJournal Article | $23.10 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.